Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

NeuroThera® Efficacy and Safety Trial - 3 (NEST-3) A Double-blind, Randomized, Sham-controlled, Parallel Group, Multicenter, Pivotal Study to Assess the Safety and Efficacy of Transcranial Laser Therapy With the NeuroThera® Laser System for the Treatment of Acute Ischemic Stroke Within 24 Hours of Stroke Onset

NCT01120301 is registered in ClinicalTrials.gov with PhotoThera, Inc as lead sponsor.

NCT NCT01120301
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01120301 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
NeuroThera® Efficacy and Safety Trial - 3 (NEST-3) A Double-blind, Randomized, Sham-controlled, Parallel Group, Multicenter, Pivotal Study to Assess the Safety and Efficacy of Transcranial Laser Therapy With the NeuroThera® Laser System for the Treatment of Acute Ischemic Stroke Within 24 Hours of Stroke Onset
Lead sponsor
PhotoThera, Inc
Phase
Phase 3
Overall status
Completed
Start date
September 30, 2010
Completion date
Not reported
Enrollment
1,000 (estimated)
Sites
60

Conditions

As the registry lists them; a condition with its own page is linked.

acute ischemic stroke